Neuroendocrine tumours trials in Canada

In Canada 16 Also abroad 244

16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Calgary, Toronto
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 3Taking people
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Where
Calgary, Ottawa, Toronto
Age
18 years and over
People
390 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00
Phase 2Taking people
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
Where
London, Ottawa, Québec, St. John's, Toronto, Vancouver, Winnipeg
Age
18 years and over
People
100 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05773274
Phase 1Taking people
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Where
Montreal, Toronto
Age
18 years and over
People
104 worldwide
Run by
RayzeBio, Inc.
See details and how to joinNCT07165132
Phase 2/3Taking people
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Where
London, Ottawa, Toronto
Age
18 years and over
People
440 worldwide
Run by
Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00
Phase 1Taking people
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Where
Toronto
Age
18 years and over
People
24 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05687123
No phaseNot yet taking people in Canada
A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
Where
Vancouver
Age
18 years and over
People
60
Run by
British Columbia Cancer Agency
See details and how to joinNCT07621146
No phaseTaking people
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
Where
Toronto
Age
18 years and over
People
800
Run by
University Health Network, Toronto
See details and how to joinNCT05196087
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Montreal
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Where
Edmonton, London, Montreal, Toronto
Age
12 years to 100 years
People
240 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00
Phase 2Taking people
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
Where
Edmonton, London, Ottawa, Regina, Saskatoon, Toronto, Vancouver
Age
18 years and over
People
78 worldwide
Run by
Australasian Gastro-Intestinal Trials Group
See details and how to joinNCT06345079
No phaseTaking people
Project: Every Child for Younger Patients With Cancer
Where
Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
Age
Up to 25 years
People
75,000 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT02402244
Phase 2Taking people
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
Where
Edmonton
People
600
Run by
University of Alberta
See details and how to joinNCT04888481
Phase 3Taking people
18F-DOPA II - PET Imaging Optimization
Where
Edmonton
People
800
Run by
University of Alberta
See details and how to joinNCT04706910
No phaseTaking people
Life Following Excision of Neuroendocrine Tumors
Where
Toronto
Age
18 years and over
People
246
Run by
Sunnybrook Health Sciences Centre
See details and how to joinNCT06981455
No phaseTaking people
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
Where
Calgary
Age
18 years to 100 years
People
500
Run by
Alberta Health services
See details and how to joinNCT05673031